CRYBG1 and prostate cancer: Interestingly, there was a strong direct correlation between AIM1 mRNA levels and AIM1 copy-number loss in primary prostate cancers, which could also be confirmed in paired analysis of tumors and associated tumor-adjacent benign tissues (Supplementary Fig. 5H–J)13.